This filing is not a market-moving event. Traders should await upcoming clinical trial catalysts (e.g., Phase III MAVERIC data for recurrent pericarditis) or financial results for material directional moves. The fireside chat itself is unlikely to contain new material information.
Price Chart
Executive Summary
Cardiol Therapeutics announced its participation in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit on July 16, 2026. The filing contains no material financial data, clinical results, or strategic updates — it is a routine investor relations event.
Key Facts
- Cardiol Therapeutics will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit on July 16, 2026 at 12:20 p.m. EDT in Boston, MA.
- The company's lead drug candidate is CardiolRx™, which has Orphan Drug Designation for pericarditis.
- No financial figures, clinical trial results, or guidance were disclosed in this filing.
Financial Impact
No financial impact from this filing — it is a routine conference participation announcement.
Risk Factors
- No new risks disclosed; the company's existing pipeline and regulatory risks remain unchanged.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000651 |
| Document: cardiol6k.htm | 0001279569-26-000651 |
| Document: 0001279569-26-000651-index-headers.html | 0001279569-26-000651 |
| Document: 0001279569-26-000651-index.html | 0001279569-26-000651 |
| Document: 0001279569-26-000651.txt | 0001279569-26-000651 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | SC 13G/A | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 23, 2026 4w ago | 6-K | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 16, 2026 5w ago | 6-K | $1.90 | awaiting T+60 | — | $1.14 (−40.00%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 9, 2026 6w ago | 6-K | $2.29 | awaiting T+60 | — | $1.14 (−50.11%) |
Aug 5, 2026 11w ago | 6-K | $1.34 | awaiting T+60 | — | $1.14 (−14.93%) |
Jul 14, 2026 15w ago | 6-K | $1.15 $1.32 | ▲ +14.78% | ▲ +11.41% | $1.14 (−0.87%) |
Jul 9, 2026 15w ago | 6-K | $0.9920 $1.41 | ▲ +42.14% | ▲ +40.50% | $1.14 (+14.92%) |
May 26, 2026 22w ago | 6-K | $1.30 $1.96 | ▲ +50.77% | ▲ +48.04% | $1.14 (−12.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers